In 2027, healthcare inflation and expanding medical liability exposure will be key drivers of losses across the Mexican insurance market. Rising hospital, pharmaceutical and medical technology costs will drive claims inflation across healthcare lines. This will increase the value of both treatment-related losses and liability claims. At the same time, claimants are increasingly relying on complex evidence to support claims for future medical expenses, loss of earning capacity and moral damages. Courts may continue to show greater sensitivity to patient rights and long-term health impacts. This combination of economic pressures and evolving judicial standards will challenge traditional underwriting assumptions and increase reserving uncertainty. This may place upward pressure on medical malpractice and healthcare liability portfolios. As a result, insurers and reinsurers will need to reassess pricing and wordings as healthcare-related claims become more complex and volatile.